Barrios-López, J.M.; Triviño-Ibáñez, E.M.; Piñeiro-Donis, A.; Segovia-Román, F.; Pérez García, M.d.C.; Marín-Romero, B.; Romero Villarrubia, A.; Guillén Martínez, V.; Martínez-Barbero, J.P.; Piñar Morales, R.;
et al. Baseline Findings from Dual-Phase Amyloid PET Study in Newly Diagnosed Multiple Sclerosis: Exploring Its Potential as a Biomarker of Myelination and Neurodegeneration. J. Pers. Med. 2025, 15, 520.
https://doi.org/10.3390/jpm15110520
AMA Style
Barrios-López JM, Triviño-Ibáñez EM, Piñeiro-Donis A, Segovia-Román F, Pérez García MdC, Marín-Romero B, Romero Villarrubia A, Guillén Martínez V, Martínez-Barbero JP, Piñar Morales R,
et al. Baseline Findings from Dual-Phase Amyloid PET Study in Newly Diagnosed Multiple Sclerosis: Exploring Its Potential as a Biomarker of Myelination and Neurodegeneration. Journal of Personalized Medicine. 2025; 15(11):520.
https://doi.org/10.3390/jpm15110520
Chicago/Turabian Style
Barrios-López, José María, Eva María Triviño-Ibáñez, Adrián Piñeiro-Donis, Fermín Segovia-Román, María del Carmen Pérez García, Bartolomé Marín-Romero, Ana Romero Villarrubia, Virginia Guillén Martínez, José Pablo Martínez-Barbero, Raquel Piñar Morales,
and et al. 2025. "Baseline Findings from Dual-Phase Amyloid PET Study in Newly Diagnosed Multiple Sclerosis: Exploring Its Potential as a Biomarker of Myelination and Neurodegeneration" Journal of Personalized Medicine 15, no. 11: 520.
https://doi.org/10.3390/jpm15110520
APA Style
Barrios-López, J. M., Triviño-Ibáñez, E. M., Piñeiro-Donis, A., Segovia-Román, F., Pérez García, M. d. C., Marín-Romero, B., Romero Villarrubia, A., Guillén Martínez, V., Martínez-Barbero, J. P., Piñar Morales, R., Barrero Hernández, F. J., Mínguez-Castellanos, A., & Gómez-Río, M.
(2025). Baseline Findings from Dual-Phase Amyloid PET Study in Newly Diagnosed Multiple Sclerosis: Exploring Its Potential as a Biomarker of Myelination and Neurodegeneration. Journal of Personalized Medicine, 15(11), 520.
https://doi.org/10.3390/jpm15110520
